BR0007084A - Fortificante de leite humano em pó, dose unitária de fortificante de leite humano em pó, e, processos para prover nutrientes suplementares a lactentes de pré-termo, para promover o desenvolvimento de um bebê prematuro, para intensificar a estabilidade da emulsão de um leite humano e para impedir a desnaturação da proteìna em leite humano enriquecido - Google Patents

Fortificante de leite humano em pó, dose unitária de fortificante de leite humano em pó, e, processos para prover nutrientes suplementares a lactentes de pré-termo, para promover o desenvolvimento de um bebê prematuro, para intensificar a estabilidade da emulsão de um leite humano e para impedir a desnaturação da proteìna em leite humano enriquecido

Info

Publication number
BR0007084A
BR0007084A BR0007084-0A BR0007084A BR0007084A BR 0007084 A BR0007084 A BR 0007084A BR 0007084 A BR0007084 A BR 0007084A BR 0007084 A BR0007084 A BR 0007084A
Authority
BR
Brazil
Prior art keywords
human milk
fortifier
powdered
powder
promote
Prior art date
Application number
BR0007084-0A
Other languages
English (en)
Inventor
Bridget M Barrett-Reis
Patricia A Reynolds
Michael B Montalto
Deborah L O' Connor
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22435984&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0007084(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0007084A publication Critical patent/BR0007084A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206Colostrum; Human milk
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/801Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"FORTIFICANTE DE LEITE HUMANO EM Pó, DOSE UNITáRIA DE FORTIFICANTE DE LEITE HUMANO EM Pó, E, PROCESSOS PARA PROVER NUTRIENTES SUPLEMENTARES A LACTENTES DE PRé-TERMO, PARA PROMOVER O DESENVOLVIMENTO DE UM BEBê PREMATURO, PARA INTENSIFICAR A ESTABILIDADE DA EMULSãO DE UM LEITE HUMANO E PARA IMPEDIR A DESNATURAçãO DA PROTEìNA EM LEITE HUMANO ENRIQUECIDO". A invenção diz respeito a um fortificante de leite humano em pó, compreendendo um componente protéico tipicamente presente em uma quantidade de cerca de 24% p/p a cerca de 55% p/p do pó fortificante, e um componente gorduroso tipicamente presente em uma quantidade de cerca de 1% p/p a cerca de 30% p/p do pó fortificante, e um componente de carboidrato presente em uma quantidade de cerca de 15% p/p a cerca de 75% p/p do pó fortificante. Preferivelmente, o fortificante de leite humano em pó é fornecido em um recipiente de dose unitária, que contém de cerca de 0,5 g a cerca de 10 g de pó. A presente invenção também diz respeito a um processo de proporcionar nutrição a lactentes, mediante adição de um pó fortificante ao leite humano e administração do leite humano enriquecido a um bebê prematuro. A invenção ainda provê um processo de promover o crescimento de um bebê prematuro, administrando-lhe o leite humano enriquecido.
BR0007084-0A 1999-04-09 2000-04-07 Fortificante de leite humano em pó, dose unitária de fortificante de leite humano em pó, e, processos para prover nutrientes suplementares a lactentes de pré-termo, para promover o desenvolvimento de um bebê prematuro, para intensificar a estabilidade da emulsão de um leite humano e para impedir a desnaturação da proteìna em leite humano enriquecido BR0007084A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12857599P 1999-04-09 1999-04-09
PCT/US2000/009301 WO2000060949A2 (en) 1999-04-09 2000-04-07 Powdered human milk fortifier

Publications (1)

Publication Number Publication Date
BR0007084A true BR0007084A (pt) 2002-09-10

Family

ID=22435984

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007084-0A BR0007084A (pt) 1999-04-09 2000-04-07 Fortificante de leite humano em pó, dose unitária de fortificante de leite humano em pó, e, processos para prover nutrientes suplementares a lactentes de pré-termo, para promover o desenvolvimento de um bebê prematuro, para intensificar a estabilidade da emulsão de um leite humano e para impedir a desnaturação da proteìna em leite humano enriquecido

Country Status (20)

Country Link
US (3) US6294206B1 (pt)
EP (1) EP1168929B2 (pt)
JP (2) JP4755762B2 (pt)
CN (1) CN1353577A (pt)
AR (1) AR023414A1 (pt)
AT (1) ATE298200T1 (pt)
AU (1) AU770601B2 (pt)
BR (1) BR0007084A (pt)
CA (1) CA2369007C (pt)
CO (1) CO5170426A1 (pt)
DE (1) DE60020945D1 (pt)
ES (1) ES2243252T5 (pt)
HK (1) HK1045082B (pt)
IL (2) IL145395A0 (pt)
MX (1) MX223614B (pt)
NZ (1) NZ514164A (pt)
PH (1) PH12000000861B1 (pt)
SA (1) SA00210206B1 (pt)
TW (1) TWI256881B (pt)
WO (1) WO2000060949A2 (pt)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6596302B2 (en) * 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
US6716466B2 (en) * 2001-01-17 2004-04-06 Nestec S.A. Balanced food powder composition
US6620427B2 (en) * 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US20070098863A1 (en) * 2005-09-23 2007-05-03 Prolacta Bioscience, Inc. Method for collecting, testing and distributing milk
US20070203802A1 (en) * 2005-09-23 2007-08-30 Prolacta Bioscience, Inc. Method for collecting, testing and distributing milk
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US20060039958A1 (en) * 2003-05-28 2006-02-23 Monosolrx, Llc. Multi-layer films having uniform content
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
ATE383076T1 (de) * 2002-02-04 2008-01-15 Bristol Myers Squibb Co Muttermilchzusatz
MXPA06003704A (es) * 2003-10-02 2006-06-20 Bio Balance Corp Una composicion bioterapeutica seca, usos, y dispositivo y metodos para administracion de la misma.
US20070009490A1 (en) * 2003-10-02 2007-01-11 Conte Anthony E Dried biotherapeutic composition, uses, and device and methods for administration thereof
AU2004279621A1 (en) * 2003-10-14 2005-04-21 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20080118615A1 (en) * 2004-09-10 2008-05-22 Medela Holding Ag Method for Analysing and Treating Human Milk and System Therefore
US20080187619A1 (en) * 2004-09-10 2008-08-07 Medela Holding Ag Human Milk Fortifiers and Methods for Their Production
EP1637043A1 (en) * 2004-09-17 2006-03-22 Medela Holding AG Human milk fortifiers and methods for their production
EP1637880A1 (en) * 2004-09-17 2006-03-22 Medela Holding AG Method for analysing and treating human milk and system therefor
WO2006039264A1 (en) 2004-09-30 2006-04-13 Monosolrx, Llc Multi-layer films having uniform content
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
US20060233915A1 (en) * 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
CA2623483A1 (en) * 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
US20070118078A1 (en) * 2005-11-18 2007-05-24 Mcnally David J Method and apparatus for controlled feeding of an infant
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
NZ568611A (en) 2005-12-19 2011-11-25 Abbott Lab Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
US20070243290A1 (en) * 2006-04-18 2007-10-18 Melody Thompson Method of tailoring infant formulas to individual nutritional needs prior to use
WO2008027572A1 (en) * 2006-08-30 2008-03-06 Prolacta Bioscience Methods of obtaining sterile milk and compositions thereof
CN105123950A (zh) * 2006-11-29 2015-12-09 普罗莱克塔生物科学公司 人乳组合物及其制备和使用方法
ES2396571T3 (es) * 2006-12-08 2013-02-22 Prolacta Bioscience, Inc. Composiciones de lípidos humanos y procedimientos de preparación y utilización de los mismos
WO2008119163A1 (en) * 2007-03-29 2008-10-09 The Hospital For Sick Children Multi-nutrient milk fortifier
BRPI0808601B1 (pt) * 2007-04-16 2018-06-12 Unilever N.V. Emulsão comestível água-em-óleo compreendendo um mineral e processo para produzir tal emulsão
AU2008254417B2 (en) * 2007-05-18 2013-05-30 Mjn U.S. Holdings Llc Acidified liquid human milk supplement
RU2481008C2 (ru) 2007-12-20 2013-05-10 Абботт Лаборэтриз Композиции питательного порошка и детской питательной смеси (варианты)
WO2009153249A1 (en) * 2008-06-19 2009-12-23 Unilever Nv Fat containing edible emulsions with iron and zinc
EA200801650A1 (ru) * 2008-06-20 2008-12-30 Лев Михайлович МОГИЛЕВСКИЙ Сухая молочная смесь
JP2010126495A (ja) * 2008-11-28 2010-06-10 Morinaga Milk Ind Co Ltd 母乳添加用粉末
US8927027B2 (en) 2008-12-02 2015-01-06 Prolacta Bioscience Human milk permeate compositions and methods of making and using same
US9149452B2 (en) * 2009-04-20 2015-10-06 Women's & Children's Health Research Institute Inc. Methods and compositions for promoting the neurological development of an infant
WO2010134800A1 (en) 2009-05-19 2010-11-25 N.V. Nutricia Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution
AU2011210682A1 (en) 2010-01-29 2012-07-05 Abbott Laboratories Aseptically packaged nutritional liquids comprising HMB
AU2011210691A1 (en) 2010-01-29 2012-07-12 Abbott Laboratories Nutritional emulsions comprising calcium HMB
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
WO2011144221A1 (en) * 2010-05-18 2011-11-24 N.V. Nutricia Preterm milk formula
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣hmb及可溶性蛋白質之實質上透明營養液
US20130243904A1 (en) * 2010-08-24 2013-09-19 Abbott Laboratories Nutritional products having improved organoleptic properties
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
MX336759B (es) * 2010-11-02 2016-01-29 Abbott Lab Fortificante concentrado liquido estable para leche materna.
US9539269B2 (en) 2010-12-31 2017-01-10 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
CA2842672A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US10820604B2 (en) 2011-08-03 2020-11-03 Prolacta Bioscience, Inc. Microfiltration of human milk to reduce bacterial contamination
NL2007268C2 (en) * 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
PL2790522T3 (pl) 2011-12-14 2015-10-30 Nestec Sa Zemulgowany produkt spożywczy zawierający mleczne białko
JP5878361B2 (ja) * 2011-12-20 2016-03-08 テルモ株式会社 栄養強化用粉末食品
EA201201023A1 (ru) * 2012-08-10 2013-02-28 Лев Михайлович МОГИЛЕВСКИЙ Быстрорастворимый молочный напиток
US20140057014A1 (en) * 2012-08-27 2014-02-27 Carol Lynn Berseth Formula Fortifier
EA020389B1 (ru) * 2012-10-01 2014-10-30 Ооо "Фармацевтическая Компания "Славянская Аптека" Фармацевтический состав, содержащий натрий, железо, цинк и обладающий метаболическим, противокатарактным, ретинопротекторным действием (варианты)
EA020388B1 (ru) * 2012-10-01 2014-10-30 Ооо "Фармацевтическая Компания "Славянская Аптека" Фармацевтический состав, содержащий натрий, кальций, железо, цинк и обладающий метаболическим, противокатарактным, ретинопротекторным действием (варианты)
JP6080508B2 (ja) * 2012-11-07 2017-02-15 テルモ株式会社 術後食
MX2015012205A (es) 2013-03-13 2016-05-26 Prolacta Bioscience Inc Productos de leche humana altos en grasa.
RU2685187C2 (ru) * 2013-11-29 2019-04-16 Нестек С.А. Жидкая композиция обогатителя молока с относительно высоким содержанием липидов
WO2016086128A1 (en) 2014-11-25 2016-06-02 Abbott Laboratories Method of improving visual processing, visual acuity, or both by administering compositions comprising rrr-alpha-tocopherol and carotenoid to infants
EP3240429A4 (en) * 2014-12-30 2018-12-05 Prolacta Bioscience, Inc. Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products
EP3397064A4 (en) * 2015-12-30 2019-10-30 Prolacta Bioscience, Inc. HUMAN MILK PRODUCTS USEFUL IN PRE- AND POST-OPERATIVE CARE
CA3022840A1 (en) 2016-05-05 2017-11-09 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CN111479564A (zh) * 2017-12-01 2020-07-31 雀巢产品有限公司 人乳强化剂组合物
TW201924696A (zh) * 2017-12-01 2019-07-01 瑞士商耐斯泰克公司 母體補充劑
JP2021523687A (ja) * 2018-05-22 2021-09-09 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 栄養組成物
AU2020200778A1 (en) * 2019-02-07 2020-08-27 Aggarwal, Rakesh Kumar A dry powdered human milk fortifier
WO2020168439A1 (en) 2019-02-22 2020-08-27 Aquero Canada Ltd. Fortified milk compositions and their processes of preparation
US20200282135A1 (en) * 2019-03-07 2020-09-10 Kpr U.S., Llc Delivery of fluid from a syringe
WO2021146561A1 (en) * 2020-01-17 2021-07-22 Prolacta Bioscience, Inc. Feeding protocol for optimal growth of preterm infants
CN111807598B (zh) * 2020-06-18 2022-03-11 西南科技大学 一种电场协同磷尾矿无害化处理电解锰渣渗滤液的方法
EP4042875A1 (en) * 2021-02-15 2022-08-17 Rakesh Kumar Aggarwal A human milk fortifier
WO2022200526A1 (de) * 2021-03-24 2022-09-29 Ammeva Gmbh Getrocknete frauenmilch zum einsatz als nahrungsergänzungsmittel, lebensmittel für besondere medizinische zwecke und als alleinnahrungsmittel für säuglinge

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD228951A3 (de) * 1982-12-02 1985-10-23 Inst Getreideverarbeitung Verfahren zur herstellung von granulierter nahrung
EP0129418B1 (en) * 1983-06-16 1988-10-05 Farley Health Products Limited Infant foods
US4692370A (en) * 1984-08-23 1987-09-08 Henkel Kommanditgesellschaft Auf Aktien Process for nonslip finishing of smooth surfaces of objects and objects produced thereby
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
JP2516794B2 (ja) * 1988-02-26 1996-07-24 雪印乳業株式会社 ビタミンd代謝産物を配合した育児用調製乳
US5013569A (en) 1990-05-21 1991-05-07 Century Laboratories, Inc. Infant formula
JP3247206B2 (ja) * 1993-06-11 2002-01-15 明治乳業株式会社 ミルク組成物
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
WO1996010922A1 (de) * 1994-10-05 1996-04-18 Milupa Aktiengesellschaft Phospholipidhaltige fettmischung mit lcp-fettsäuren
EP0799577B1 (en) 1994-10-14 2001-02-14 Morinaga Milk Industry Co., Ltd. Peptide mixture and products thereof
JPH09131163A (ja) * 1995-11-09 1997-05-20 Miyoshi Oil & Fat Co Ltd レシチンを含有する粉末
JP3920969B2 (ja) * 1997-08-04 2007-05-30 雪印乳業株式会社 栄養組成物
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier

Also Published As

Publication number Publication date
CA2369007A1 (en) 2000-10-19
JP4755762B2 (ja) 2011-08-24
CO5170426A1 (es) 2002-06-27
CA2369007C (en) 2009-09-29
EP1168929A2 (en) 2002-01-09
US20030021868A1 (en) 2003-01-30
IL145395A (en) 2010-05-31
IL145395A0 (en) 2002-06-30
TWI256881B (en) 2006-06-21
SA00210206B1 (ar) 2005-11-23
ES2243252T5 (es) 2012-05-23
EP1168929B1 (en) 2005-06-22
HK1045082B (zh) 2006-04-21
DE60020945D1 (de) 2005-07-28
WO2000060949A3 (en) 2001-03-01
MXPA01010013A (es) 2002-05-06
MX223614B (es) 2004-10-18
US6472003B2 (en) 2002-10-29
CN1353577A (zh) 2002-06-12
JP2002540806A (ja) 2002-12-03
ATE298200T1 (de) 2005-07-15
US6294206B1 (en) 2001-09-25
AU4212500A (en) 2000-11-14
AU770601B2 (en) 2004-02-26
NZ514164A (en) 2003-03-28
WO2000060949A2 (en) 2000-10-19
AR023414A1 (es) 2002-09-04
HK1045082A1 (en) 2002-11-15
ES2243252T3 (es) 2005-12-01
US20020031576A1 (en) 2002-03-14
PH12000000861B1 (en) 2006-11-21
JP2011172569A (ja) 2011-09-08
EP1168929B2 (en) 2012-01-18

Similar Documents

Publication Publication Date Title
BR0007084A (pt) Fortificante de leite humano em pó, dose unitária de fortificante de leite humano em pó, e, processos para prover nutrientes suplementares a lactentes de pré-termo, para promover o desenvolvimento de um bebê prematuro, para intensificar a estabilidade da emulsão de um leite humano e para impedir a desnaturação da proteìna em leite humano enriquecido
CA2371696A1 (en) Composition for an infant formula having a low threonine content
RU2002130509A (ru) Композиции и способы улучшения состояния сосудистой системы
CA2274839A1 (en) Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
DE69002201T2 (de) Formulierung zur Behandlung der Nierenkrankheiten.
DE102006018293A1 (de) Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
Berry et al. Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine, and leucine
JP2008174512A (ja) 起床時疲労感改善用組成物
Howland Dietary supplement drug therapies for depression
Kleiner The true nature of herbs
JP2004189619A (ja) 滋養強壮剤
Spies Some recent advances in nutrition
HU227182B1 (en) Lecitin-ascorbic acid combination
KR20010044152A (ko) 타조 엑기스 제조방법
Kolata Brain biochemistry: Effects of diet
JP6840647B2 (ja) 液体組成物、その白濁改善剤、臭気改善剤、及び製造方法
US20200215149A1 (en) N-Phenylacetyl-L-prolylglycine ethyl ester compositions and methods for using the same
JP2002500869A (ja) 加水分解したタンパク質を含む栄養食品中のビタミンdの安定性を改善する方法および該方法により得られる食品
CA2232134A1 (en) Use of threonine for the treatment of phenylketonuria
FR2811204A1 (fr) Composition d'un complement nutritionnel et polyactif
RU2138972C1 (ru) Мясные консервы для детского питания
Ahuja et al. An unusual presentation of scurvy following head injury
US20220184030A1 (en) N-Phenylacetyl-L-prolylglycine ethyl ester compositions and methods for using the same
Ekong et al. Exploring micronutrient supplements in disease conditions: are they effective? Micronutrient supplements in disease conditions
US20060189585A1 (en) Dosage and method for attaining beneficial levels of vitamin D3

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A,8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.

B15K Others concerning applications: alteration of classification

Ipc: A23C 9/20 (2006.01), A23C 11/04 (2006.01)